Medicenna Therapeutics

(TSX) MDNA

Current PriceCA$0.40

Market CapCA$27.15M

Since IPO (2017)-85%

5 Year-89%

1 Year-54%

1 Month-7%

Medicenna Therapeutics Financials at a Glance

Market Cap

CA$27.15M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$18.41M

EPS (TTM)

-CA$0.22

P/E Ratio

-1.78

Dividend

CA$0.00

Beta (Volatility)

1.04 (Average)

Dividend

CA$0.00

Beta (Volatility)

1.04 (Average)

Price

CA$0.40

Volume

36,006

Open

CA$0.40

Price

CA$0.40

Volume

36,006

Open

CA$0.40

Previous Close

CA$0.40

Daily Range

CA$0.40 - CA$0.40

52-Week Range

CA$0.38 - CA$1.97

Estimated Earnings Date

Jul 30, 2026

Dividend

CA$0.00

Beta (Volatility)

1.04 (Average)

Price

CA$0.40

Volume

36,006

Open

CA$0.40

Previous Close

CA$0.40

Daily Range

CA$0.40 - CA$0.40

52-Week Range

CA$0.38 - CA$1.97

Estimated Earnings Date

Jul 30, 2026

MDNA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medicenna Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Fahar Merchant, PhD

Website

www.medicenna.com

Headquarters

Toronto, ON M4W 3E2, CA

MDNA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-219.30%

Return on Capital

-911.57%

Return on Assets

-217.75%

Earnings Yield

-56.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$27.15M

Shares Outstanding

68.74M

Volume

36.01K

Avg. Volume

103.99K

Financials (TTM)

Gross Profit

-CA$77.00K

Operating Income

-CA$23.71M

EBITDA

-CA$23.05M

Operating Cash Flow

-CA$17.92M

Capital Expenditure

CA$9.44M

Free Cash Flow

-CA$13.45M

Cash & ST Invst.

CA$6.25M

Total Debt

CA$119.00K

Medicenna Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$19.00K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

CA$27.15M

N/A

Market Cap/Employee

CA$1.70M

N/A

Employees

N/A

Net Income

-CA$4.23M

-456.7%

EBITDA

-CA$7.10M

-24.5%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

CA$6.25M

-74.8%

Total Debt

CA$119.00K

-29.2%

Accounts Receivable

CA$1.35M

-50.1%

Inventory

CA$0.00

N/A

Long Term Debt

CA$54.00K

-54.6%

Short Term Debt

CA$65.00K

-33.7%

Return on Assets

-2.18%

N/A

Return on Invested Capital

-7.93%

N/A

Free Cash Flow

CA$0.00

+100.0%

Operating Cash Flow

-CA$4.48M

+10.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MIR.VMedMira Inc.

MIR.VMedMira Inc.CA$0.07+0.00%

SVA.TOSernova Corp.

SVA.TOSernova Corp.CA$0.14+0.00%

COV.VCovalon Technologies Ltd.

COV.VCovalon Technologies Ltd.CA$2.21+5.24%

ZEN.VZentek Ltd.

ZEN.VZentek Ltd.CA$0.64-1.54%

MDP.TOMedexus Pharmaceuticals Inc.

MDP.TOMedexus Pharmaceuticals Inc.CA$5.16+1.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.62+0.01%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$5.54+0.10%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$12.76+0.05%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$4.94+0.00%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.47+0.10%

MARAMara Holdings

MARAMara Holdings$13.70+0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$35.09+0.03%

Questions About MDNA

What is the current price of Medicenna Therapeutics?

Medicenna Therapeutics is trading at CA$0.40 per share.

What is the 52-week range for Medicenna Therapeutics?

Over the past 52 weeks, Medicenna Therapeutics has traded between CA$0.38 and CA$1.97.

How much debt does Medicenna Therapeutics have?

As of the most recent reporting period, Medicenna Therapeutics reported total debt of CA$119.00K.

How much cash does Medicenna Therapeutics have on hand?

Medicenna Therapeutics reported CA$6.25M in cash and cash equivalents in its most recent financial results.

What is Medicenna Therapeutics’s dividend yield?

Medicenna Therapeutics does not currently have a dividend yield.

Medicenna Therapeutics

Medicenna Therapeutics Financials at a Glance

MDNA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Medicenna Therapeutics

MDNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Medicenna Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDNA

What is the current price of Medicenna Therapeutics?

What is the 52-week range for Medicenna Therapeutics?

How much debt does Medicenna Therapeutics have?

How much cash does Medicenna Therapeutics have on hand?

What is Medicenna Therapeutics’s dividend yield?

Premium Investing Services